Business Context and Reporting Period
Important filing identity issue: The supplied filing is for Rosewind Corporation, a development-stage sailing-school business—not AYTU Biopharma, Inc. It reports the quarter ended May 31, 2012, and the nine months then ended. Investors should verify that this is the intended filing before relying on the figures.
Rosewind’s stated business is offshore sailing instruction using its vessel. The company reported limited operating history and only one student who had paid for instruction since inception; it received a further $1,750 tuition deposit during the nine-month period.
Financial Results and Liquidity
- Revenue: No revenue was reported for the three or nine months ended May 31, 2012. The $1,750 deposit for future lessons was recorded as unearned revenue. Since inception, reported revenue totaled $1,750.
- Loss: Net loss was $11,940 for the quarter and $41,687 for the nine months. Nine-month loss per share was $0.01. No meaningful margin comparison is available because there was no current-period revenue.
- Operating costs: Nine-month operating expenses were $39,185, down from $62,885 a year earlier. Management attributed the improvement primarily to lower boat repair and maintenance and management expenses while the yacht was docked and not in use.
- Cash flow: Nine-month operating cash use was $25,285, compared with $55,520 in the prior-year period. Financing provided $21,340, including $18,212 from stock issuance and $4,128 in related-party loan proceeds, net of $1,000 in loan repayments. Cash fell from $3,993 to $48.
- Balance sheet at May 31, 2012: Total assets were $14,026, including $48 cash and $13,824 net property and equipment. Current liabilities were $68,956; shareholders’ deficit was $54,930. The company disclosed a working-capital deficit of $68,754.
- Debt and related parties: A $55,428 secured loan from the sole officer and director bears 6% interest, is payable on demand, and is secured by the vessel. Accrued related-party interest was $7,652.
Changes Versus the Prior Comparable Period
- Nine-month net loss improved to $41,687 from $65,265, a decrease of $23,578 (36%), according to management.
- Nine-month operating expenses declined by $23,700. The filing attributes the main reduction to lower vessel repair, maintenance, and management costs.
- Cash declined by $3,945 during the nine months, from $3,993 to $48. Related-party loans and stock sales funded most cash needs.
- Common shares outstanding increased from 4,734,658 at August 31, 2011 to 4,856,068 at May 31, 2012.
Outlook, Risks, and Unusual Items
- Management provided no quantified revenue, earnings, or cash-flow guidance. It said it intended to seek additional funding through equity offerings, with no assurance of success.
- The filing raises substantial doubt about the company’s ability to continue as a going concern: losses have accumulated since inception, cash was only $48, and management stated current liquidity was insufficient to sustain the business.
- Key disclosed risks include inability to attract students or raise capital, ongoing vessel maintenance and public-company costs, potentially costly or unclear licensing requirements, limited insurance, operational and maritime safety hazards, and dependence on a sole officer/director and key personnel.
- The filing says disclosure controls were effective and reports no material change in internal control over financial reporting during the quarter.
- There are apparent inconsistencies to clarify: one risk disclosure says the company had identified and complied with applicable vessel requirements, while another says it had not identified or attempted to comply with requirements in any jurisdiction. The reported vessel location and the balance-sheet presentation of the $1,750 tuition deposit also warrant confirmation.
Most Important Facts to Verify
- Confirm whether this Rosewind Corporation filing is actually the intended filing; the request identifies AYTU Biopharma, Inc.
- Verify the filing period and issuer directly against the SEC filing record.
- Confirm available cash, near-term obligations, and whether the demand loan from the sole officer remains outstanding and can be repaid or extended.
- Determine whether the company obtained additional financing or generated student revenue after the reporting date.
- Reconcile the disclosures about vessel licensing, vessel location, and the accounting classification of the tuition deposit.